Get startedLog in
    Picture of Aarti Pharmalabs logo

    AARTIPHARM — Aarti Pharmalabs Cashflow Statement

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Aarti Pharmalabs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

    2021
    March 31st
    2022
    March 31st
    R2023
    March 31st
    2024
    March 31st
    Period Length:12 M12 M12 M12 M
    Source:Interim ReportInterim ReportARSARS
    Standards:——
    IAS
    IAS
    Status:FinalFinalFinalFinal
    Net Income/Starting Line-0.0461,5542,6083,005
    Depreciation
    Non-Cash Items—103217245
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital0.046-2,515-950-1,818
    Change in Accounts Receivable
    Change in Inventories
    Change in Accounts Payable
    Other Operating Cash Flow
    Cash from Operating Activities0-4372,5012,164
    Capital Expenditures—-1,412-1,197-1,988
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items—24.1-381-158
    Sale/Maturity of Investment
    Change in Net Investments
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities—-1,387-1,578-2,146
    Financing Cash Flow Items—-120-211-172
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Debt
    Cash from Financing Activities—2,604-1,63597.2
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash0779-712115